These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6809629)

  • 1. Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.
    Frasch CE; Peppler MS
    Infect Immun; 1982 Jul; 37(1):271-80. PubMed ID: 6809629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations.
    Peppler MS; Frasch CE
    Infect Immun; 1982 Jul; 37(1):264-70. PubMed ID: 6809628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and physicochemical and immunological characterization of polysaccharide-outer membrane protein complexes of Neisseria meningitidis.
    Beuvery EC; Miedema F; van Delft RW; Haverkamp J; Leussink AB; te Pas BJ; Teppema KS; Tiesjema RH
    Infect Immun; 1983 Apr; 40(1):369-80. PubMed ID: 6403470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of meningococcal outer membrane protein vaccines solubilized with detergent or C polysaccharide.
    Poolman JT; Timmermans HA; Hopman CT; Teerlink T; Van Vught PA; Witvliet MH; Beuvery EC
    Antonie Van Leeuwenhoek; 1987; 53(6):413-9. PubMed ID: 3130780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.
    Moreno C; Lifely MR; Esdaile J
    Infect Immun; 1985 Feb; 47(2):527-33. PubMed ID: 3917979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.
    Zollinger WD; Mandrell RE; Griffiss JM; Altieri P; Berman S
    J Clin Invest; 1979 May; 63(5):836-48. PubMed ID: 109466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.
    Devi SJ; Zollinger WD; Snoy PJ; Tai JY; Costantini P; Norelli F; Rappuoli R; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1045-52. PubMed ID: 9038314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal group B vaccine trial in Norway 1981--1982. Preliminary report of results available November 1982.
    Frøholm LO; Berdal BP; Bøvre K; Gaustad P; Harboe A; Holten E; Høiby EA; Lystad A; Omland T; Frasch CE
    NIPH Ann; 1983 Dec; 6(2):133-8. PubMed ID: 6427703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
    Zollinger WD; Moran EE; Devi SJ; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    Skevakis L; Frasch CE; Zahradnik JM; Dolin R
    J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
    Frasch CE; Robbins JD
    J Exp Med; 1978 Mar; 147(3):629-44. PubMed ID: 416164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine.
    Frasch CE; Zahradnik JM; Wang LY; Mocca LF; Tsai CM
    J Infect Dis; 1988 Oct; 158(4):710-8. PubMed ID: 3139776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model.
    Wang LY; Frasch CE
    Infect Immun; 1984 Nov; 46(2):408-14. PubMed ID: 6437983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.
    Milagres LG; Ramos SR; Sacchi CT; Melles CE; Vieira VS; Sato H; Brito GS; Moraes JC; Frasch CE
    Infect Immun; 1994 Oct; 62(10):4419-24. PubMed ID: 7927704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine.
    Rosenqvist E; Tjade T; Frøholm LO; Frasch CE
    NIPH Ann; 1983 Dec; 6(2):139-49. PubMed ID: 6427704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
    Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
    J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide.
    Vodopija I; Baklaic Z; Hauser P; Roelants P; André FE; Safary A
    Infect Immun; 1983 Nov; 42(2):599-604. PubMed ID: 6417019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.